Though the role of transthyretin (TTR) in the development of cardiac amyloidosis has been recognized, the determinants of TTR levels remain unexplored. Here, the authors present the clinical correlates of transthyretin levels and show that reduced TTR levels are associated with an increase risk of cardiovascular disease and mortality.
- Naman S. Shetty
- Mokshad Gaonkar
- Pankaj Arora
